We are live on
!
Find out more
CUAMC
China Universal Asset Management Company Portfolio holdings
AUM
$1.67B
1-Year Est. Return
89%
This Fund
S&P 500
This Quarter
Est. Return
+11.72%
1 Year Est. Return
+89%
3 Year Est. Return
+264.17%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$249M
AUM Growth
+$11.2M
(+4.7%)
Cap. Flow
+$1.58M
Cap. Flow
% of AUM
0.64%
Top 10 Holdings %
Top 10 Hldgs %
35.47%
Holding
513
New
48
Increased
266
Reduced
45
Closed
120
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iQIYI
IQ
|
+$7.05M |
| 2 |
Amazon
AMZN
|
+$3.89M |
| 3 |
uniQure
QURE
|
+$2.86M |
| 4 |
BioNTech
BNTX
|
+$2.81M |
| 5 |
DexCom
DXCM
|
+$2.78M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$5.6M |
| 2 |
Procter & Gamble
PG
|
+$3.27M |
| 3 |
NVO
Novo Nordisk
NVO
|
+$3.16M |
| 4 |
CVS Health
CVS
|
+$3.1M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$2.85M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 35.23% |
| 2 | Healthcare | 25.2% |
| 3 | Consumer Discretionary | 20.47% |
| 4 | Communication Services | 8.05% |
| 5 | Financials | 3.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
251
Theravance Biopharma
TBPH
$878M
| $7.67K | ﹤0.01% |
684
-32
| -4% | -$336 |
|
|
BCYC
252
Bicycle Therapeutics
BCYC
$284M
| $7.67K | ﹤0.01% |
259
+20
| +8% | +$537 |
|
253
Sana Biotechnology
SANA
$1.13B
| $7.66K | ﹤0.01% |
1,938
+157
| +9% | +$768 |
|
254
Anavex Life Sciences
AVXL
$316M
| $7.33K | ﹤0.01% |
792
+62
| +8% | +$662 |
|
255
4D Molecular Therapeutics
FDMT
$621M
| $7.31K | ﹤0.01% |
329
+26
| +9% | +$402 |
|
256
Mirum Pharmaceuticals
MIRM
$6.04B
| $7.29K | ﹤0.01% |
374
+29
| +8% | +$573 |
|
|
MRUS
257
DELISTED
Merus
MRUS
| $7.29K | ﹤0.01% |
471
+42
| +10% | +$739 |
|
|
ALLK
258
DELISTED
Allakos
ALLK
| $7.28K | ﹤0.01% |
865
+351
| +68% | +$2.44K |
|
259
ANI Pharmaceuticals
ANIP
$1.73B
| $7.16K | ﹤0.01% |
+178
| New | +$6.69K |
|
260
Seres Therapeutics
MCRB
$47.4M
| $7.08K | ﹤0.01% |
63
+5
| +9% | +$670 |
|
|
ITOS
261
DELISTED
iTeos Therapeutics
ITOS
| $7.05K | ﹤0.01% |
361
+28
| +8% | +$547 |
|
|
DADA
262
DELISTED
Dada Nexus
DADA
| $6.97K | ﹤0.01% |
+1,000
| New | +$5.24K |
|
|
RAPT
263
DELISTED
RAPT Therapeutics
RAPT
| $6.83K | ﹤0.01% |
43
+8
| +23% | +$1.28K |
|
264
Schrodinger
SDGR
$1.39B
| $6.54K | ﹤0.01% |
350
| – | – |
|
265
Tango Therapeutics
TNGX
$4.31B
| $6.5K | ﹤0.01% |
+896
| New | +$6.3K |
|
|
EXAS
266
DELISTED
Exact Sciences
EXAS
| $6.34K | ﹤0.01% |
128
| – | – |
|
267
Castle Biosciences
CSTL
$960M
| $6.31K | ﹤0.01% |
268
+22
| +9% | +$510 |
|
|
ME
268
DELISTED
23andMe Holding Co
ME
| $6.29K | ﹤0.01% |
146
+24
| +20% | +$1.4K |
|
|
RPTX
269
DELISTED
Repare Therapeutics
RPTX
| $6.27K | ﹤0.01% |
426
+33
| +8% | +$494 |
|
270
Coherus Oncology
CHRS
$181M
| $6.26K | ﹤0.01% |
790
+62
| +9% | +$477 |
|
271
Aurinia Pharmaceuticals
AUPH
$2.06B
| $6.24K | ﹤0.01% |
1,444
+116
| +9% | +$673 |
|
272
Editas Medicine
EDIT
$436M
| $6.19K | ﹤0.01% |
698
+54
| +8% | +$593 |
|
273
Wave Life Sciences
WVE
$1.03B
| $6.18K | ﹤0.01% |
883
+70
| +9% | +$323 |
|
274
Dyne Therapeutics
DYN
$4.89B
| $6.14K | ﹤0.01% |
530
+46
| +10% | +$532 |
|
|
275
Procter & Gamble
PG
$335B
| $6.06K | ﹤0.01% |
40
-23,300
| -100% | -$3.27M |
|
Similar funds
HA
JPM
CPO
LCI
GWM
JIP
RMC
GACM
China Universal Asset Management Company's Q4 2022 Portfolio in Review
As of Q4 2022, China Universal Asset Management Company held 513 positions worth $249M, up 4.7% from $238M the previous quarter. Its ten largest holdings account for 35% of the portfolio.
China Universal Asset Management Company's Q4 2022 filing shows 48 new, 266 increased, 45 reduced and 120 closed positions. Its largest new stake was iQIYI: 2,418,500 shares worth $12.8M. The largest sale was Tesla, an estimated $5.6M.
By sector, the portfolio is most concentrated in Technology at 35% of assets, down from 36% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- China Universal Asset Management Company's largest Q4 2022 buy was iQIYI: 2,418,500 shares worth $12.8M.
- China Universal Asset Management Company added most to Amazon in Q4 2022, an estimated $3.89M increase.
- China Universal Asset Management Company's biggest Q4 2022 reduction was Tesla, cutting an estimated $5.6M.
- China Universal Asset Management Company fully exited Sprott Physical Gold in Q4 2022, selling an estimated $2.3M.
- China Universal Asset Management Company's ten largest holdings make up 35% of its $249M portfolio in Q4 2022.
- China Universal Asset Management Company opened 48 new positions and closed 120 in Q4 2022.
- China Universal Asset Management Company's portfolio value rose 4.7% quarter-over-quarter to $249M.
Based on China Universal Asset Management Company's 13F filing for Q4 2022, filed 31 Jan 2023.